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Abstract
Background: Responding to errors is a critical first step in learning from mistakes, a process that is abnormal in
schizophrenia. To gain insight into the neural and molecular mechanisms of error processing, we used functional MRI to
examine effects of a genetic variant in methylenetetrahydrofolate reductase (MTHFR 677C.T, rs1801133) that increases risk
for schizophrenia and that has been specifically associated with increased perseverative errors among patients. MTHFR is a
key regulator of the intracellular one-carbon milieu, including DNA methylation, and each copy of the 677T allele reduces
MTHFR activity by 35%.
Methodology/Principal Findings: Using an antisaccade paradigm, we found that the 677T allele induces a dose-dependent
blunting of dorsal anterior cingulate cortex (dACC) activation in response to errors, a pattern that was identical in healthy
individuals and patients with schizophrenia. Further, the normal relationship between dACC activation and error rate was
disrupted among carriers of the 677T allele.
Conclusions/Significance: These findings implicate an epigenetic mechanism in the neural response to errors, and provide
insight into normal cognitive variation through a schizophrenia risk gene.
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Introduction
Learning from mistakes is fundamental to adaptive, flexible
behavior. To correct course, we must recognize and respond to
errors, processes mediated by the dorsal anterior cingulate cortex
(dACC). Individuals who mount stronger dACC responses to
errors ultimately make fewer mistakes [1]. But what underlies
variation in dACC function during errors? As suggested by
previous work [2,3], genetic factors likely contribute. However,
epigenetic variables such as DNA methylation and chromatin
remodeling could also modulate the brain’s responsiveness to
errors, as they play an essential role in neural plasticity [4]. While
epigenetic phenomena cannot be measured directly in the living
brain, we have used functional MRI to investigate whether a
genetic variant in methylenetetrahydrofolate reductase (MTHFR)
that strongly influences the one-carbon milieu also regulates
dACC activity during error processing.
MTHFR is a key supplier of one-carbon moieties for intrace-
llular methylation reactions, including DNA methylation and
homocysteine metabolism. Specifically, MTHFR irreversibly
reduces 5,10-methylenetetrahydrofolate (5,10-MTHF), which is
derived from dietary folate intake, to 5-methyltetrahyrdofolate (5-
MTHF). In turn, 5-MTHF supplies one-carbon moieties for
downstream methylation reactions, including those catalyzed by
methionine synthetase, DNA methyltransferases, and other vital
transmethylation reactions. A common, well-characterized variant
in the MTHFR gene, rs1801133 (677C.T) causes an amino acid
substitution (222Ala.Val), each copy of which confers a 35%
reduction in MTHFR activity [5]. Accordingly, individuals who
carry the 677T allele exhibit lower genomic DNA methylation,
especially in the setting of low serum folate, which supplies the
substrate for MTHFR [6]. Reduced global DNA methylation has
also been observed in heterozygous and homozygous Mthfr
knockout mice [7], with numerous consequences for neurodevel-
opment and behavior. Mthfr 2/2 mice exhibit pronounced
deficits including developmental retardation, altered cerebellar
cytoarchitecture, and reduced survival at 5 weeks of age [7], while
heterozygotes appear more grossly normal but exhibit hyperloco-
motion and impaired recognition memory [8].
MTHFR 677C.T genotype has also been studied in relation to
a variety of neuropsychiatric illnesses [9,10]. A meta-analysis of 20
case-control studies indicated that the 677T variant augments risk
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responses to errors [1] and rigid, perseverative behavior. Further,
the 677T allele increases perseverative errors in schizophrenia
[12], and was associated with diminished error-related dACC
activation in a preliminary study of 18 patients [13]. However, as
patient studies are confounded by the effects of chronic illness,
including co-morbidities and antipsychotic use, it is unclear
whether MTHFR effects on error processing in schizophrenia
represent an epiphenomenon or a core aspect of the illness.
Another possibility, one with broader implications for cognitive
neuroscience, is that MTHFR exerts a more fundamental effect on
error processing that transcends diagnosis, a plausible notion given
the importance of one-carbon metabolism to normal brain
development and function [4]. Here, we addressed this possibility
by examining effects of MTHFR genotype on error-related brain
activation in a cohort of 25 healthy individuals and 31
demographically matched patients with schizophrenia.
Participants underwent functional MRI using a 3.0 T scanner
equipped for echo planar imaging (Siemens Medical Systems,
Erlangen, Germany). During scanning participants performed a
variant of the antisaccade task, which requires a gaze away from a
suddenly appearing visual stimulus. Errors occur when partici-
pants fail to inhibit the prepotent response of looking towards the
stimulus. Schizophrenia patients consistently show a higher
antisaccade error rate and lower error-related activation of the
dACC than healthy individuals [1]. We initially focused on
regions-of-interest in the bilateral dACC, comparing error-related
activation, based on the contrast of erroneous versus correct
antisaccades, in C homozygotes and T allele carriers (i.e., C/T
and T/T genotypes combined).
The dACC is a structurally and functionally heterogeneous
region. In addition to its contributions to error processing, it is also
thought to exert ‘top-down’ control on other ocular motor regions
during preparation for antisaccades [14]. To determine the
specificity of the MTHFR effect on error processing, we also
examined whether MTHFR influenced dACC activation related to
the preparation and execution of antisaccades, a different aspect of
dACC function.
Methods
Ethics
The study was approved by the Partners HealthCare Human
Research Committee. All participants provided written informed
consent.
Participants
The study included 31 outpatients with chronic schizophrenia,
recruited from an urban mental health center, and 25 demo-
graphically matched healthy subjects, who were recruited from the
community by poster and website advertisements (Table 1).
Patients and healthy participants were different from those
included in a previous MRI investigation [1,13] that used a
different version of the antisaccade task. Participants were
excluded if they had a history of substance abuse or dependence
within the previous 6 months, a history of significant head injury,
Table 1. Characteristics of study participants.
SCHIZOPHRENIA PATIENTS HEALTHY PARTICIPANTS
MTHFR genotype C/C (n=14)
C/T (n=13) plus T/T
(n=4) C/C (n=13)
C/T (n=9) plus T/T
(n=3) P*
DEMOGRAPHICS
Age at fMRI 40634 5 634 1 633 9 64n / s
S e x 1 2M ,2F 1 2M ,5F 1 0M ,3F 1 0M ,2F n / s
Race 9 European, 5 Other 14 European, 3 Other 12 European, 1 Other 9 European, 3 Other n/s
Length of illness (yrs) 19641 9 63– – n / s
Edinburgh handedness 64614 57613 57615 6768n / s
CLINICAL
PANSS positive 15651 4 64– – n / s
PANSS negative 14651 5 65– – n / s
PANSS general 30693 1 68– – n / s
CPZ equivalents 435694 465678 – – n/s
PERFORMANCE AND MOTION
Estimated verbal IQ 101639 7 631 0 6 64 11064 healthy.patient, p=.01
Antisaccade latency (ms)
N correct trials 300616 277614 276612 272614 n/s
N error trials 202613 189610 185610 183615 n/s
Antisaccade % error 26663 2 651 3 631 8 63 patient.healthy, p=.004
Post-error slowing (ms;
positive=slower)**
1667 24671 3 687 68C / C .T, p=.08
Average motion (mm) 2.3360.28 2.4360.25 1.9860.29 2.3160.30 n/s
Statistical tests were performed using ANOVA or chi-square as appropriate, with alpha (2-tailed)=0.05. Abbreviations: fMRI, functional magnetic resonance imaging;
PANSS, positive and negative syndrome scale; CPZ, chlorpromazine.
*n/s, no significant main effects of genotype or diagnosis, or significant genotype6diagnosis interaction.
**Post-error slowing was calculated as the difference in saccadic latency between correct trials following an error and correct trials immediately prior to errors.
doi:10.1371/journal.pone.0025253.t001
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exclude a personal history of Axis I mental illness [15] or a family
history of schizophrenia-spectrum disorder. Patient diagnoses were
confirmed using the Structured Clinical Interview for DSM-IV-
TR [16]. Patients had been maintained on stable doses of second
generation antipsychotics for at least six weeks, with the exception
of one patient taking prolixin, and three patients who were not
taking any medications.
MRI acquisition
Images were acquired with a 3.0 T Siemens Trio whole body
high-speed imaging device equipped for echo planar imaging
(Siemens Medical Systems, Erlangen, Germany) and a 12-channel
head coil. The protocol included a high-resolution MP-RAGE
structural scan. Functional images were acquired using a gradient
echo T2* weighted sequence that included prospective acquisition
correction (PACE) for head motion [17]. Thirty-two contiguous
horizontal slices, parallel to the intercommissural plane, were
collected interleaved (TR/TE/flip=2000 ms/30 ms/90u, voxel
size 3.163.163.7 mm).
Antisaccade task
We used a modified version of the antisaccade task described in
[1] that consisted of three pseudorandomly intermixed types of
antisaccade trials and fixation epochs (Fig. 1). Trials lasted 4 s and
began with a central instructional cue for 300 ms, either a blue or
yellow ‘‘X’’, indicating whether the trial was ‘‘Hard’’ or ‘‘Easy.’’
Color assignment was counterbalanced across participants. The cue
was followed by a white central fixation ring (1500 ms), and then a
gap (200 ms) between the disappearance of the fixation ring and the
appearance of the imperative stimulus, which appeared 10u to the
right or left of the center. Participants were instructed to look away
from the stimulus. ‘‘Hard’’ trials (40%) involved a distraction during
the gap: a 3 dB luminance increase of the two peripheral squares
that marked the potential locations of stimulus appearance. During
easy trials (50%), luminance was unchanged. ‘‘Fake Hard’’ trials
(10%) presented a hard cue but were otherwise identical to easy
trials in that they lacked the luminance change; these trials were
included as a control condition that would allow examination of the
effects of a ‘‘Hard’’ versus ‘‘Easy’’ cue on fMRI activation
unconfounded by the change in luminance that characterizes
‘‘Hard’’ trials. Participants practiced the task in a mock scanner.
During fMRI scanning they performed six runs, each lasting 5 min
16 s, generating a total of 384 antisaccade trials and 120 fixation
epochs. They received 5 cents for each correct response in addition
to a base rate of pay. The ISCAN fMRI Remote Eye Tracking
Laboratory (ISCAN, Burlington, MA) recorded eye position during
scanning [see [1]]. Errors were combined across all trial types
(‘‘Hard,’’ ‘‘Easy,’’ and ‘‘Fake Hard’’) for analysis.
MTHFR genotype
DNA was extracted from whole blood samples, and MTHFR
677C.T genotype was determined using the MassArray platform
(Sequenom, San Diego), using previously described primers [18]. As
our a priori hypothesis focused exclusively on the MTHFR 677C.T
polymorphism in relation to error-related dACC activation based on
our preliminary study [13], this was the only genotype we
investigated. Genotyping was conducted following acquisition of
MRI scans. The observed minor allele (677T) frequency was similar
(0.33) to that reported in the 1000 Genomes Project (0.32) [19].
MRI analysis
Analyses were conducted on the cortical surface using Free-
Surfer [20] and FS-FAST [21] software. Finite impulse response
(FIR) estimates [21] of the event-related hemodynamic responses
were calculated for error and correct trials for each participant. As
in prior studies [1,13,22] we compared activation in error versus
correct antisaccades at 6 s after trial onset, which is the peak of
error-related dACC activation based on the averaged data of all
participants. We also examined the contrast of correct anti-
saccades versus fixation at 4 s to determine whether MTHFR
genotype affected activation related to generating a correct
antisaccade. The correct antisaccades versus fixation contrast
peaked at 4 s after trial onset across all participants.
Cortical activation was localized using an automated surface-
based parcellation that delineated the cingulate cortex [23] and
subdivided it into dorsal and rostral ACC, and posterior cingulate
cortex regions [24]. Regions-of-interest (ROIs) were defined for
the left and right dACC using both anatomical and functional
constraints [see [13]; briefly, the dACC was defined using an
automated parcellation of the cortical surface [25], and for each
participant, the ROIs were functionally constrained to vertices
within the dACC that showed error-related activation at p,.05
based on the averaged data of all 56 participants]. We averaged
activation across all the vertices in each dACC ROI for each
participant and used these values in repeated measures ANOVAs,
with genotype and diagnosis as between-subject factors and
condition (error or correct) and hemisphere as within-subject
factors.
To explore effects outside of the dACC, we examined the effects
of genotype (C/C versus T carrier) in the entire group (n=56), as
well as separately in patients (n=31) and healthy participants
(n=25), on error-related activation across the entire cortical
surface and subcortical brain volume. We also conducted a
factorial genotype6diagnosis analysis for error-related activation.
To correct for multiple comparisons, 10,000 Monte Carlo
simulations of synthesized white Gaussian noise were run on the
cortical surface and in the volume, using the same smoothing,
Figure 1. Schematic and timeline of the three trial types: Easy,
Hard, and Fake Hard. For fMRI analyses comparing error and correct
responses, we did not distinguish between trial types. All trials begin
with an instructional cue (300 ms) of a color (blue or yellow) indicating
either a Hard or Easy trial, followed by fixation. At 1800 ms, the central
fixation ring disappears (200 ms gap), and at 2000 ms, it re-appears on
either the right or left side as the imperative stimulus to which
participants must respond. Hard trials are distinguished by an increase
in luminance of both the peripheral squares that mark the potential
locations of stimulus appearance during the gap and of the imperative
stimulus. Except for the Hard cue, Fake Hard trials are identical to Easy
trials. In the trials depicted, the correct response is a saccade away from
the stimulus on the left side of the display. An error would involve a
saccade towards the stimulus. After one second, the fixation ring
returns to the center, where participants return their gaze to await the
next trial.
doi:10.1371/journal.pone.0025253.g001
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This determines the likelihood that a cluster of a certain size at a
certain threshold (p,.01) would be found by chance (cluster-wise
probability). These methods set the corrected overall probability
level to 0.05 (2-tailed).
Results
Error-related dACC activation
MTHFR genotype significantly influenced dACC activation
bilaterally in the combined group of patients and healthy
participants (genotype6condition interaction, F1,52=13.4,
p=.001), with T allele carriers exhibiting blunted error-related
activation in each diagnostic group (Fig. 2a, b). We observed no
significant diagnosis6condition (F1,52=0.01, p=.92) or genoty-
pe6diagnosis6condition (F1,52=0.35 p=.56) interactions. As a
test of possible population stratification artifact, the analysis was
repeated using only participants of European ancestry (n=44).
Again, we observed significantly greater error-related activation in
C/C than T allele carrier participants (genotype6condition
interaction, F1,40=10.9, p=.002), with no significant diagnosis6
condition (F1,40=0.19, p=.67) or genotype6diagnosis6condition
(F1,40=1.5, p=.24) interactions.
To determine the specificity of the MTHFR effect on error
processing, we examined whether MTHFR influenced dACC
activation related to the preparation and execution of antisaccades
in the contrast of correct antisaccades versus fixation at 4 s [22].
Despite robust antisaccade-related activation of the dACC, there
was no genotype effect (Fig. 3) suggesting that MTHFR effects
were specific to error processing.
Allele-load effects
As measures of intracellular methylation increase linearly with
677C allele load (0, 1, or 2 copies) [5], we next assessed whether a
similar allele load effect would characterize error-related dACC
activation. Linear regression in the combined group (n=56)
Figure 2. Effects of MTHFR 677C.T genotype on error-related dACC activation. Both schizophrenia patients (a) and healthy participants (b)
exhibited significant condition6genotype interactions (patients: F=4.51, p=.042; healthy participants: F=10.32, p=.004) indicating that C/C
participants, but not T allele carriers, showed significant error-related dACC activation. (c) Pseudocolor statistical maps of the relationship between
677C allele load (0, 1, or 2 copies) and error-related activation (error minus correct) in the combined group, displayed on the inflated medial cortical
surface. The dACC is outlined in green. Graphs illustrate the effects of allele load on error-related activation, averaged across vertices in the
anatomically defined dACC, for patients and healthy participants. Error bars indicate the standard error of the mean.
doi:10.1371/journal.pone.0025253.g002
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as a function of 677C allele load (left: r=.49, p=.0001; right:
r=.44, p=.001), a pattern that was nearly identical in patients
and healthy participants when examined separately (Fig. 2c). The
results were similar when only participants of European origin
were included in the analysis (n=44; left: r=.51, p=.0004; right:
r=.48, p=.001).
Association with error rate
Although 677T carriers made more errors, and showed a trend
towards decreased post-error slowing, these effects did not reach
significance (Table 1). This pattern is consistent with stronger
effects of genotype on measures of brain function than perfor-
mance, a common finding in imaging-genetics studies [26]. Only
C/C participants, however, showed the expected [1] inverse
relation of dACC activation with error rate (C/C r=.43, p=.02;
T allele carrier: r=.11, p=.56; see Fig. 4), and this relation did
not differ by diagnostic group. Among individuals of European
origin, dACC activation again correlated with error rate among
C/C (r=.44, p=.04) but not T allele carrier (r=.21, p=.33)
participants.
Whole brain analysis
To determine whether MTHFR genotype influenced error-
related activation outside the dACC, we examined the effects of
C/C versus T carrier genotype across the entire cortical surface
and within the subcortical brain volume (Table 2). All analyses
were controlled for multiple comparisons using cluster thresholds
based on Monte Carlo simulations. Significant C/C.T effects on
the inferior frontal gyrus were observed, regardless of diagnosis.
Several additional regions that have previously been implicated in
error processing [1], most prominently the bilateral insula, showed
C/C.T effects in healthy but not patient participants. Converse-
ly, in the left frontal pole, patients but not healthy participants
exhibited significant C/C.T error-related activation. However,
none of these regions exhibited significant genotype6diagnosis
effects in the factorial interaction analysis conducted with all
participants.
Two regions outside of the error processing network, the left
fusiform gyrus and left hippocampus/parahippocampal gyrus,
exhibited significant C/C.T error-related activation in healthy
participants but not patients, as also reflected in a significant
genotype6diagnosis interaction. A third region outside of the error
processing network, the right superior parietal cortex, did not
show significant genotype effects in either patients or healthy
participants when these groups were studied separately, but did
demonstrate a significant genotype6diagnosis interaction. In all
three regions with significant genotype6diagnosis interactions,
patients showed a reverse pattern of T carrier.C/C effects,
although these effects did not reach significance in the patient-only
group analysis.
Discussion
The identification of genetic risk variants that influence
neuropsychiatric disease risk or alter the course of illness has
provided new insights into the neural and molecular mechanisms
that underlie normal human cognition [26]. The MTHFR
677C.T variant is one of only a small number of functional
polymorphisms that have been consistently associated with
schizophrenia risk [11], and specifically with cognitive impairment
among schizophrenia patients [12,27]. Here, we found that both
healthy participants and schizophrenia patients who carried the
low-methyl 677T variant exhibited blunted error-related dACC
activation, and that the magnitude of dACC activation was
predicted by allele load. Previous work demonstrated that when
genotype is not taken into account, the degree of error-related
dACC activation predicts performance (error rate), suggesting the
Figure 3. Pseudocolor statistical maps of MTHFR 677C.T genotype effects in the contrast of correct antisaccades versus fixation at
4 s displayed on the left inflated medial cortical surface. This contrast examines activation related to correctly performing an antisaccade at
the time point that shows maximal activation in ocular motor regions in the combined group data. We observed robust activation in the ocular motor
network, including in the cingulate eye field (which is within the dACC), that did not differ by genotype group. The dACC is outlined in green.
doi:10.1371/journal.pone.0025253.g003
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However, here we found this relationship to be disrupted among
all participants who carried the 677T allele, regardless of
diagnosis. To the extent that MTHFR 677C.T genotype indexes
genomic methylation status in vivo, as seen in previous work [6,7],
this finding suggests a novel epigenetic mechanism for under-
standing the neural response to errors.
In addition to its association with reduced global DNA
methylation [6], the 677T allele also induces hypomethylation
within glioblastoma cells [28] and promoter hypomethylation
within colon cancer genes [29]. Similarly, altered DNA or histone
methylation in the setting of the low-functioning 677T allele could
influence the expression of other genes salient to error processing,
although the mechanism by which these genes might be selectively
targeted remains unknown. Previous work suggests that the 677T
allele potentiates the metabolism of dopamine [12,30], which has
been postulated to modulate error-related dACC activation via
striatal projections [31], and strongly influences prefrontally-
mediated executive function [32]. However, other mechanisms
could contribute to MTHFR effects on error processing circuitry;
for example the 677T allele also inhibits the metabolism of
homocysteine [6], which is toxic to dopamine neurons in culture
[33]. It is also important to note that other regions in which
dopamine neurons are putatively involved in error processing,
such as the striatum, did not show MTHFR effects on error-related
fMRI activation in the present study. Additional work is needed to
understand the apparent selectivity of MTHFR 677C.T effects on
dACC activation during error processing despite the more global
effect of this variant on intracellular methylation processes.
The only previous study to examine effects of MTHFR genotype
on brain function in healthy individuals found no significant effects
of the 677T allele onworkingmemory load-dependent prefrontal or
dACC activation [30]. Among schizophrenia patients who
participated in the same study, the 677T allele was associated with
reduced dorsolateral prefrontal, but not dACC activation. This is
consistent with our present findings that MTHFR genotype did not
mediate the dACC response during the preparation and execution
of antisaccades in either the patient or healthy groups. The dACC is
thought to play a role in top-down control of motor regions while
performing cognitively demanding tasks. Taken together these
findings suggest an MTHFR effect on dACC function during error
processing, but not on cognitive control during other executive
function tasks (working memory or antisaccade generation).
Although the 677T allele has been consistently associated with
increased schizophrenia risk [11], the mechanisms underlying this
association remain uncertain. In the present study MTHFR
genotype effects within the dACC were similar in similar patients
and healthy participants, suggesting that by itself, the 677T variant
does not contribute to error processing deficits in schizophrenia any
more so than it does in the general population. However, in the
context of altered prefrontal physiology, functional consequences of
677T allele-related dACC blunting during errors may be
exacerbated in schizophrenia. Genome-wide profiling of DNA
methylation using postmortemprefrontal cortex tissue has indicated
numerous sites with altered methylation in schizophrenia, including
genes that regulate glutamate and GABA signaling [34]. The
presence of the hypofunctional 677T allele could augment these
differences across a number of metabolic pathways that contribute
to schizophrenia, not only those salient to error processing.
It is also noteworthy that error-related MTHFR genotype effects
outside of the dACC differed in patients and healthy participants.
Significant genotype6diagnosis interactions were observed in the
left fusiform gyrus, left hippocampus, and right superior parietal
cortex.ThesefindingswerelargelydrivenbyC/C.T carriereffects
that were unique to healthy participants, although interestingly
patients exhibited non-significant T carrier.C/C effects within
these regions. These interactions were not expected, as they
occurred in regions that are not typically associated with error
processing. Within the error processing network, only healthy
participants demonstrated significant C/C.T carrier effects in
bilateral insula, but did not differ significantly from patients in this
regard (i.e., the genotype6diagnosis interaction was not significant).
The interpretation of these findings is not straightforward, and they
should be considered preliminary until replicated. Still, in light of
equivalent task performance by genotype within each diagnostic
group, these patterns could provide insights into differing
Figure 4. Relation of error-related dACC activation with antisaccade error rate in C/C (a) and T carrier (b) participants. Gray triangles
indicate data points from schizophrenia patients; black circles indicate healthy participants.
doi:10.1371/journal.pone.0025253.g004
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both within and external to the error processing network.
Epigenetic mechanisms are dynamic and reversible, even in
mature neurons [35]. Folate status, in particular, may influence
the degree to which hypofunctional MTHFR variants influence
downstream methylation events. Among healthy individuals
homozygous for the 677T allele, genomic DNA methylation and
homocysteine metabolism are substantially lower than for those
with C/C genotype, differences that are even more pronounced in
the setting of low serum folate levels [6]. Similarly, among T/T
schizophrenia patients, those with low folate levels exhibit more
severe negative symptoms (which are closely related to cognitive
impairment), while those with high folate exhibit more favorable
negative symptom scores (similar to C/C and C/T patients, for
whom negative symptom scores do not depend on folate levels)
[18]. Among schizophrenia patients who carry the 677T allele and
who receive folate supplementation, improvement in negative
symptoms scores correlates with increase in serum folate level [36].
It is possible that folate level might also modulate the neural
response to errors in 677T allele carriers and that folate
supplementation might augment it, suggesting a potential
intervention for blunted learning from errors.
Limitations
There are several limitations to the present study. As direct
observation of MTHFR genotype effects on downstream methyl-
ation measures is not possible in vivo, we cannot directly ascribe the
MTHFR effect on error-related neural activation to specific
patterns of DNA or histone methylation. In addition, dietary or
serum folate levels were not available from study participants,
precluding the study of interactive folate6MTHFR genotype
effects on dACC function. The number of participants in each
genotype6diagnosis group was relatively small. However, that the
results were nearly identical in two groups (healthy participants
and patients) and also echo those seen in a previous, smaller study
of schizophrenia patients that used a different version of the
antisaccade paradigm[13], suggests a low likelihood of Type I
error. Finally, although study participants were predominantly
Caucasian, the use of a racially admixed cohort raises the
possibility of population stratification artifact; however, MTHFR
genotype groups did not differ with regard to racial composition,
and MTHFR effects persisted when only participants of European
origin were included in the analysis, diminishing this concern.
Conclusion
In summary, the present results demonstrate that a genetic
variant implicated in schizophrenia risk alters the neural response
to errors. They also suggest the importance of epigenetic control
over error processing circuitry, implicating a novel molecular
mechanism for how we regulate and flexibly modify our behavior.
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Table 2. Regions with significant (p,.05) effects of genotype on antisaccade error-related activation following whole-brain
correction.
Hemisphere Region
Maximal
activation
Talairach coordinates
(x, y, z) Size (mm
2)
Cluster-wise
probability Comments
COMBINED GROUP (N=56)
Left Dorsal ACC 1.8610
26 29, 26, 33 1161 1.0610
24 C/C.T carrier
Frontal pole 4.6610
26 222, 53, 14 1146 1.0610
24 C/C.T carrier
Fusiform gyrus 8.5610
25 229, 275, 24 1313 1.0610
24 C/C.T carrier
Inferior frontal gyrus 1.2610
24 240, 24, 6 925 8.0610
24 C/C.T carrier
Right Dorsal ACC 1.8610
24 7, 30, 20 607 2.5610
22 C/C.T carrier
HEALTHY PARTICIPANTS ONLY (N=25)
Left Fusiform gyrus 2.2610
25 228, 273, 23 1984 1.0610
24 C/C.T carrier
Anterior insula 7.4610
25 231, 27, 28 1135 1.0610
24 C/C.T carrier
Dorsal ACC 5.5610
24 210, 24, 33 509 2.8610
22 C/C.T carrier
Parahippocampal gyrus 6.5610
24 221, 233, 28 534 2.2610
22 C/C.T carrier
Supramarginal gyrus 7.7610
24 250, 250, 22 903 1.0610
23 C/C.T carrier
Superior parietal cortex 9.5610
24 219, 272, 42 1217 1.0610
24 C/C.T carrier
Right Anterior insula 3.8610
25 35, 9, 29 1083 2.0610
24 C/C.T carrier
SCHIZOPHRENIA PATIENTS ONLY (N=31)
Left Frontal pole 7.2610
27 224, 56, 17 8192 2.3610
22 C/C.T carrier
GENOTYPE6DIAGNOSIS INTERACTIONS (N=56)
Left Fusiform gyrus 1.6610
24 224, 272, 0 1646 1.0610
24 Healthy: C/C.T carrier,
Patients: T carrier.C/C
Hippocampus 1.7610
24 222, 233, 213 8776 1.4610
22 Healthy: C/C.T carrier,
Patients: T carrier.C/C
Right Superior parietal cortex 4.9610
24 40, 273, 38 7496 3.9610
22 Healthy: C/C.T carrier,
Patients: T carrier.C/C
Abbreviation: ACC, anterior cingulate cortex.
doi:10.1371/journal.pone.0025253.t002
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